Abstract
Response to dexamethasone (DEXA), as a hallmark drug in the treatment of childhood acute lymphoblastic leukemia (ALL), is one of the pivotal prognostic factors in the prediction of outcome in ALL. Identification of predictive markers of chemoresistance is beneficial to selecting of the best therapeutic protocol with the lowest effect adverse. Hence, we aimed to find drug targets using the 2DE/MS proteomics study of a DEXA-resistant cell line (REH) as a model for poor DEXA responding patients before and after drug treatment. Using the proteomic methods, three differentially expressed proteins were detected, including voltage dependent anion channel 1 (VDAC1), sorting Nexin 3 (SNX3), and prefoldin subunit 6 (PFDN6). We observed low expression of three proteins after DEXA treatment in REH cells. We subsequently verified low expression of resulted proteins at the mRNA level using the quantitative PCR method. These proteins are promising proteins because of their important roles in drug resistance and regulation of apoptosis (VDAC1), protein trafficking (SNX3), and protein folding (PFDN6). Additionally, mRNA expression level of these proteins was assessed in 17 bone marrow samples from children with newly diagnosed ALL and 7 non-cancerous samples as controls. The results indicated that independent of the molecular subtypes of leukemia, mRNA expression of VDAC1, SNX3, and PFDN6 decreased in ALL samples compared with non-cancerous samples particularly in VDAC1 (p < 0.001). Additionally, mRNA expression of three proteins was also declined in high-risk samples compared with standard risk cases. These results demonstrated diagnostic and prognostic value of these proteins in childhood ALL. Furthermore, investigation of protein-protein interaction using STRING database indicated that these proteins involved in the signaling pathway of NR3C1 as dexamethasone target. In conclusion, our proteomic study in DEXA resistant leukemic cells revealed VDAC1, SNX3, and PFDN6 are promising proteins that might serve as potential biomarkers of prognosis and chemotherapy in childhood ALL.
Similar content being viewed by others
Abbreviations
- ER:
-
ETV6/RUNX1
- GC:
-
Glucocorticoid
- ALL:
-
Acute lymphoblastic leukemia
- DEXA:
-
Dexamethasone
- VDAC1:
-
Voltage dependent anion channel 1
- SNX3:
-
Sorting Nexin 3
- PFDN6:
-
Prefoldin subunit 6
- PPI:
-
Protein-protein interaction
- 2-DE:
-
Two-dimensional gel electrophoresis
- MS:
-
Mass spectrometry
- PIP3:
-
Phosphatidylinositol (3,4,5)-trisphosphate
- FCM:
-
Flow cytometry
References
Admoni-Elisha L, Nakdimon I, Shteinfer A, Prezma T, Arif T, Arbel N, Melkov A, Zelichov O, Levi I, Shoshan-Barmatz V (2016) Novel biomarker proteins in chronic lymphocytic leukemia: impact on diagnosis, prognosis and treatment. PLoS One 11, e0148500
Ara S, Kikuchi T, Matsumiya H, Kojima T, Kubo T, Ye RC, Sato A, Kon S-I, Honma T, Asakura K et al (2012) Sorting nexin 5 of a new diagnostic marker of papillary thyroid carcinoma regulates Caspase-2. Cancer Sci 103:1356–1362
Arif T, Krelin Y, Shoshan-Barmatz V (2016) Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation. Biochim Biophys Acta 1857:1228–1242
Cao S, Carlesso G, Osipovich AB, Llanes J, Lin Q, Hoek KL, Khan WN, Ruley HE (2008) Subunit 1 of the prefoldin chaperone complex is required for lymphocyte development and function. J Immunol 181:476–484
Carroll WL, Raetz EA (2012) Clinical and laboratory biology of childhood acute lymphoblastic leukemia. J Pediatr 160:10–18
Chen C, Garcia-Santos D, Ishikawa Y, Seguin A, Li L, Fegan KH, Hildick-Smith GJ, Shah DI, Cooney JD, Chen W et al (2013) Snx3 regulates recycling of the transferrin receptor and iron assimilation. Cell Metab 17:343–352
Cooper SL, Brown PA (2015) Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin N Am 62:61–73
Danson C, Brown E, Hemmings OJ, McGough IJ, Yarwood S, Heesom KJ, Carlton JG, Martin-Serrano J, May MT, Verkade P et al (2013) SNX15 links clathrin endocytosis to the PtdIns3P early endosome independently of the APPL1 endosome. J Cell Sci 126:4885–4899
Delbuono E, Maekawa YH, Latorre MRDO, Seber A, Petrilli AS, Braga JAP, Lee MLM (2008) Simplified flow cytometric assay to detect minimal residual disease in childhood with acute lymphoblastic leukemia. Rev Bras Hematol Hemoter 30:281–286
Dördelmann M, Reiter A, Borkhardt A, Ludwig WD, Götz N, Viehmann S, Gadner H, Riehm H, Schrappe M (1999) Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 94:1209–1217
Inaba H, Pui C-H (2010) Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 11:1096–1106
Jaso JM, Wang SA, Jorgensen JL, Lin P (2014) Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future. Bone Marrow Transplant 49:1129–1138
Jiang N, Kham SKY, Koh GS, Suang Lim JY, Ariffin H, Chew FT, Yeoh AEJ (2011) Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL). J Proteome 74:843–857
Jin Y, Wang X, Hu S, Tang J, Li B, Chai Y (2016) Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing. Cancer Med 5:337–351
Kumar RA, Everman DB, Morgan CT, Slavotinek A, Schwartz CE, Simpson EM (2007) Absence of mutations in NR2E1 and SNX3 in five patients with MMEP (microcephaly, microphthalmia, ectrodactyly, and prognathism) and related phenotypes. BMC Med Genet 8:48
Li X-H, Li C, Xiao Z-Q (2011) Proteomics for identifying mechanisms and biomarkers of drug resistance in cancer. J Proteome 74:2642–2649
Lipinski KA, Britschgi C, Schrader K, Christinat Y, Frischknecht L, Krek W (2016) Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1. Oncotarget 7:29635–29647
Luqmani YA (2005) Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract 14(Suppl 1):35–48
Millan-Zambrano G, Chavez S (2014) Nuclear functions of prefoldin. Open Biol 4:140085
Miyoshi N, Ishii H, Mimori K, Nishida N, Tokuoka M, Akita H, Sekimoto M, Doki Y, Mori M (2010) Abnormal expression of PFDN4 in colorectal cancer: a novel marker for prognosis. Ann Surg Oncol 17:3030–3036
Moricke A, Lauten M, Beier R, Odenwald E, Stanulla M, Zimmermann M, Attarbaschi A, Niggli F, Schrappe M (2013) Prediction of outcome by early response in childhood acute lymphoblastic leukemia. Klin Padiatr 225(Suppl 1):S50–S56
Nguyen LN, Holdren MS, Nguyen AP, Furuya MH, Bianchini M, Levy E, Mordoh J, Liu A, Guncay GD, Campbell JS et al (2006) Sorting nexin 1 down-regulation promotes colon tumorigenesis. Clin Cancer Res 12:6952–6959
Nishimura Y, Takiguchi S, Ito S, Itoh K (2014) Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line. Int J Oncol 44:412–426
Overduin M, Rajesh S, Gruenberg J, Lenoir M (2015) Secondary structure and (1)H, (13)C, (15)N resonance assignments of the endosomal sorting protein sorting nexin 3. Biomol NMR Assign 9:355–358
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45
Pons V, Ustunel C, Rolland C, Torti E, Parton RG, Gruenberg J (2012) SNX12 role in endosome membrane transport. PLoS One 7, e38949
Shoshan-Barmatz V, Ben-Hail D, Admoni L, Krelin Y, Tripathi SS (2015) The mitochondrial voltage-dependent anion channel 1 in tumor cells. Biochim Biophys Acta 1848:2547–2575
Wang P, Zhao J, Yang X, Guan S, Feng H, Han D, Lu J, Ou B, Jin R, Sun J et al (2015) PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization. Med Oncol 32:264
Wang F, Qiang Y, Zhu L, Jiang Y, Wang Y, Shao X, Yin L, Chen J, Chen Z (2016) MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis. Tumour Biol 37:10235–10246
Zhang Y, Rai M, Wang C, Gonzalez C, Wang H (2016) Prefoldin and Pins synergistically regulate asymmetric division and suppress dedifferentiation. Sci Rep 6:23735
Zhou Y, You MJ, Young KH, Lin P, Lu G, Medeiros LJ, Bueso-Ramos CE (2012) Advances in the molecular pathobiology of B-lymphoblastic leukemia. Hum Pathol 43:1347–1362
Acknowledgments
The authors would like to thank the Shahid Beheshti University of Medical Sciences for supporting of this research and also Pasteur Institute of Iran for technical assistance.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Dehghan-Nayeri, N., Rezaei-Tavirani, M., Omrani, M.D. et al. Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia. J. Cell Commun. Signal. 11, 137–145 (2017). https://doi.org/10.1007/s12079-016-0357-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-016-0357-3